lorazepam has been researched along with Tay-Sachs Disease in 1 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Tay-Sachs Disease: An autosomal recessive neurodegenerative disorder characterized by the onset in infancy of an exaggerated startle response, followed by paralysis, dementia, and blindness. It is caused by mutation in the alpha subunit of the HEXOSAMINIDASE A resulting in lipid-laden ganglion cells. It is also known as the B variant (with increased HEXOSAMINIDASE B but absence of hexosaminidase A) and is strongly associated with Ashkenazic Jewish ancestry.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosebush, PI | 1 |
| MacQueen, GM | 1 |
| Clarke, JT | 1 |
| Callahan, JW | 1 |
| Strasberg, PM | 1 |
| Mazurek, MF | 1 |
1 review available for lorazepam and Tay-Sachs Disease
| Article | Year |
|---|---|
Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues.
Topics: Adolescent; Age Factors; Age of Onset; Benzodiazepines; beta-N-Acetylhexosaminidases; Diagnosis, Dif | 1995 |